OVULATION INHIBITION WITH A LONG-ACTING PARENTERAL PROGESTOGEN-ESTROGEN COMBINATION.
D000523:Algestone; D035843:Biomedical Research; D003271:Contraceptive Agents, Female; D003273:Contraceptive Devices; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D034445:Ovulation Inhibition; D011372:Progestins; D014116:Toxicology
D003271:Contraceptive Agents, Female; D004967:Estrogens; D011372:Progestins; D000523:Algestone
CLINICAL RESEARCH; CONTRACEPTIVE DEVICES; DIHYDROXYPROGESTERONE; ESTROGENS, THERAPEUTIC; PROGESTATIONAL HORMONES; TOXICOLOGIC REPORT